Our Central Texas AbbVie nurse educators shared the below virtual educational opportunities to stay up-to-date on hematologic malignancies! For more information, please reach out to Sarah Featherston or Lisa Fisher (sarah.featherston@abbvie.com; lisa.fisher@abbvie.com).
________________________________________________________________________________________________________________________
Hematology Learning Lab - Education Series
Hi everyone! We’re Sarah and Lisa, your Oncology Nurse Educators for Hematologic Malignancies at AbbVie in your area. We’re excited to let you know that we’ll be hosting a series of quick, 30-minute virtual in-services throughout the year. With so much happening in oncology and so many new RNs, NPs, PAs, and PharmDs joining the team, we know how important it is to keep learning and stay up to date. These sessions are made to fit right into your busy days and will give you practical, valuable info to keep you on top of your game. We hope you’ll join us!
These virtual sessions are scheduled for every other Wednesday for the next few months from 7:30-8:00 AM CST. We've also planned a later session around lunchtime for April, and depending on attendance and interest, we may add these to future dates as well.
Below is the schedule for our 2026 education sessions:
|
Date
|
Time
|
Topic
|
|
Wednesday, April 8, 2026
|
7:30-8:00 AM CST
12:30-1:00 PM CST
|
Chronic Lymphocytic Leukemia (CLL)
|
|
Wednesday, April 22, 2026
|
7:30-8:00 AM CST
12:30-1:00 PM CST
|
Venclexta (Venetoclax) for 1L CLL
|
|
Wednesday, May 6, 2026
|
7:30-8:00 AM CST
|
Venclexta (Venetoclax) + Calquence (Acalabrutinib) for 1L CLL
|
|
Wednesday, May 20, 2026
|
7:30-8:00 AM CST
|
Cytopenias and Blood Transfusions
|
|
Wednesday, June 3, 2026
|
7:30-8:00 AM CST
|
GI Toxicities
|
|
Wednesday, June 17, 2026
|
7:30-8:00 AM CST
|
Venclexta (Venetoclax) for 2L CLL
|
|
Wednesday, July 1, 2026
|
7:30-8:00 AM CST
|
Shared Decision Making in CLL
|
|
Wednesday, July 15, 2026
|
7:30-8:00 AM CST
|
Acute Myeloid Leukemia (AML)
|
|
Wednesday, July 29, 2026
|
7:30-8:00 AM CST
|
Venclexta (Venetoclax) for AML
|
|
Wednesday, August 12, 2026
|
7:30-8:00 AM CST
|
Neutropenia and Infections
|
|
Wednesday, August 26, 2026
|
7:30-8:00 AM CST
|
Tumor Lysis Syndrome
|
|
Wednesday, September 9, 2026
|
7:30-8:00 AM CST
|
Cancer Related Fatigue
|
|
Wednesday, September 23, 2026
|
7:30-8:00 AM CST
|
Diffuse Large B Cell Lymphoma (DLBCL)
|
|
Wednesday, October 7, 2026
|
OFF WEEK
|
OFF WEEK
|
|
Wednesday, October 21, 2026
|
7:30-8:00 AM CST
|
Epkinly (Epcoritamab) for Diffuse Large B Cell Lymphoma (DLBCL)
|
|
Wednesday, November 4, 2026
|
7:30-8:00 AM CST
|
Cytokine Release Syndrome (CRS) & Immune Effector Cell Associated Neurotoxicity Syndrome (ICANS)
|
|
Wednesday, November 18, 2026
|
7:30-8:00 AM CST
|
Follicular Lymphoma (FL)
|
|
Wednesday, December 2, 2026
|
7:30-8:00 AM EST
|
Epkinly (Epcoritamab) for Follicular Lymphoma (FL)
|
|
Wednesday, December 16, 2026
|
7:30-8:00 AM EST
|
Managing Lymphoma Patients on Bispecific Antibodies
|
**Please accept the series and decline specific dates to avoid losing the series entirely!
If the scheduled time does not work for you, or if you wish to organize additional educational sessions at your location, please reach out via email. We’ll be happy to coordinate.
Feel free to share this schedule/invite with your team or anyone who may be interested. We welcome your feedback and look forward to seeing you all virtually!
Lisa and Sarah
https://www.genmab-pi.com/prescribing-information/epkinly-pi.pdf
https://www.rxabbvie.com/pdf/venclexta.pdf
________________________________________________________________________________
Meeting ID: 294 568 396 197 01
Phone conference ID: 539 815 594#
________________________________________________________________________________
-------------------------------------------
------------------------------
Elizabeth Wade BSN, RN, OCN
Austin, TX
------------------------------